Home / business / Biogen Bets On Depression Drug In $1.5 Billion Deal With Sage Therapeutics

Biogen Bets On Depression Drug In $1.5 Billion Deal With Sage Therapeutics

-
Biogen Inc will take a $650 million stake in Sage Therapeutics and make an upfront payment of $875 million to jointly develop and sell treatments for depression and other neurological disorders, the two companies said on Friday.

from Top Business News- News18.com
Read The Rest:timesnownews...
Biogen Bets On Depression Drug In $1.5 Billion Deal With Sage Therapeutics Biogen Bets On Depression Drug In $1.5 Billion Deal With Sage Therapeutics Reviewed by Team Exprssnews on November 27, 2020 Rating: 5

No comments:

Subscribe to: Post Comments ( Atom )
Powered by Blogger.